Baker Tilly Case Study: Global Engineering and Defense Technologies Provider Successfully Implements Deltek Costpoint
CHICAGO, IL / / May 15, 2025 / Baker Tilly:
Client background
HII Mission Technologies (Huntington Ingalls Industries) is the largest military shipbuilder and a global engineering and defense technologies provider, with over 135 years in trusted partnerships with the US national security.
As HII has evolved and built a longstanding shipbuilding legacy, they've advanced to provide delivery critical technology solutions. These include unmanned systems, artificial intelligence and machine learning, synthetic training, electronic warfare, and C5ISR: Command, Control, Computers, Communications, Cyber, Intelligence, Surveillance and Reconnaissance. HII's ongoing digital transformation efforts extend into all business areas and impact the entire workforce.
The business challenge
When HII completed an acquisition that doubled its size, two ERP systems needed to be combined to ensure operations went smoothly. The newly acquired company needed to be quickly converted into the same ERP system that HII had been relying upon for so many years.
Integrating such an enormous entity into HII's Costpoint infrastructure would be a challenging project. HII has over 7,000 employees, with all of them using their timekeeping capabilities and Costpoint. In addition, HII works with 1,200 subcontractors that also rely on the time system, program managers and project controllers, all managing and monitoring projects and back-office staff.
Baker Tilly, as a Deltek system's integrator, worked with HII and synchronized systems across the two organizations and ensured the needs of both sides were met.
Strategy and solution
Deltek Costpoint has been HII's ERP of choice for operations management for more than two decades. As Costpoint's ERP is project-based and built specifically for government contractors, it offers an all-in-one system delivering innovation and intelligence across the project lifecycle.
Baker Tilly helped HII implement Costpoint for the newly acquired company. Despite the size and complexity of the implementation, Baker Tilly successfully completed the project in months.
"I think it's important to focus on the scale and timeline of this project," says Colt Meraw, Senior Manager on Baker Tilly's team. "HII acquired a multibillion-dollar company that was running on a JAMIS system, and we were able to successfully complete a mid-year conversion within just six months."
As part of the integration project, Baker Tilly also worked closely with Deltek Global Consulting's data conversion team to help them translate requirements and convert and validate data. Having completed in June 2022, and experiencing six months on a combined system, HII is still harvesting benefits and seeing huge success.
Why choose Baker Tilly
Baker Tilly was Deltek's first strategic alliance partner to provide consultancy services as part of their ERP implementation project. Helping government contractors leverage technology solutions through specialist knowledge and project management rigor.
By leveraging Deltek Costpoint in the Cloud, HII will be able to embrace its future of enterprise transformation and solidify its position as the nation's largest military shipbuilder.
Interested in learning more? Connect with a Baker Tilly specialist today.
View additional multimedia and more ESG storytelling from Baker Tilly on 3blmedia.com.
Contact Info:
Spokesperson: Baker TillyWebsite: https://www.3blmedia.com/profiles/baker-tillyEmail: info@3blmedia.com
SOURCE: Baker Tilly
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
18 hours ago
- Bloomberg
Blackstone Leads $1.5 Billion Financing for Baker Tilly Merger
Blackstone Inc. led a private credit deal of around $1.5 billion to support Baker Tilly 's merger with Moss Adams, according to a person with knowledge of the matter. The new debt consists of a $925 million term loan, a $400 million delayed draw term loan and a $130 million revolving credit facility, said the person, who asked not to be identified discussing private information. The financing is alongside $1 billion of privately placed existing debt, they said.
Yahoo
3 days ago
- Yahoo
Baker Tilly and MediSpend Expand complianceNOW suite with Launch of stewardshipNOW to Transform Life Sciences Compliance
CHICAGO, June 02, 2025--(BUSINESS WIRE)--Building on its collaboration with MediSpend, leading advisory, tax and assurance firm Baker Tilly announces the expansion of its healthcare compliance platform, complianceNOW, with the launch of stewardshipNOW, a comprehensive compliance solution that streamlines external funding management for life sciences organizations. Powered by MediSpend, and building off of the success of engagementNOW, stewardshipNOW automates the administration of grants, charitable contributions, sponsorships and investigator-initiated research funding. The solution helps life sciences companies align healthcare funding initiatives with corporate values while meeting evolving regulatory requirements. With configurable workflows, customizable portals and robust compliance oversight, stewardshipNOW simplifies funding processes from submission through payment execution and reconciliation. "stewardshipNOW empowers life sciences companies to manage the complexities with external funding in a compliant, ethical and efficient way," said Darren Jones, Baker Tilly principal, life sciences consulting. "Our collaboration with MediSpend combines strategic insight with advanced technology, helping organizations reduce administrative burden, mitigate risk and execute their funding strategies with confidence and integrity." Life sciences organizations rely on solutions like stewardshipNOW to manage programs for continuing medical education, charitable contributions, corporate sponsorships and patient advocacy funding. Baker Tilly supports organizations in developing global philanthropy strategies, implementing robust compliance controls and driving impactful funding initiatives that respect recipient independence and align with corporate values. "stewardshipNOW marks an important next step in our continued collaboration with Baker Tilly, bringing together our built for purpose technology along with their advisory experience to help life sciences organizations more effectively create and run efficient, transparent and compliant funding programs." said Seth Houston, Chief Commercial Officer at MediSpend. "We're excited to continue our collaboration with Baker Tilly to support our shared clients as they make impactful contributions to the healthcare industry." Baker Tilly and MediSpend together deliver technology-enabled solutions that help life sciences organizations navigate complex global regulations, reduce risk and improve operational efficiency. The firm's complianceNOW suite also includes: transparencyNOW – A user-friendly platform that streamlines data capture, collection and reporting while helping organizations stay ahead of evolving regulations. engagementNOW – A comprehensive solution for managing engagements and interactions with healthcare professionals. kolNOW – An on-demand, self-service portal that streamlines the process of evaluating the expertise of key opinion leaders (KOLs) used in consulting engagements. fmvNOW – Direct, self-service access to fair market value (FMV) hourly rates across key opinion leader (KOL) tiers, serving as the delivery mechanism for fair market value rate analysis. For more information about Baker Tilly's complianceNOW solutions, visit: # # # About Baker Tilly ( Baker Tilly is a leading advisory, tax and assurance firm, providing clients with a genuine coast-to-coast and global advantage in major regions of the U.S. and in many of the world's leading financial centers – New York, London, San Francisco, Los Angeles, Chicago and Boston. Baker Tilly Advisory Group, LP and Baker Tilly US, LLP (Baker Tilly) provide professional services through an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly US, LLP is a licensed independent CPA firm that provides attest services to its clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and business advisory services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities are not licensed CPA firms. Baker Tilly Advisory Group, LP and Baker Tilly US, LLP, trading as Baker Tilly, are independent members of Baker Tilly International, a worldwide network of independent accounting and business advisory firms in 143 territories, with 43,500 professionals and a combined worldwide revenue of $5.62 billion. Visit or join the conversation on LinkedIn, Facebook and Instagram. About MediSpend ( MediSpend's best-in-class solutions empower life sciences companies to grow their business compliantly through top-rated solutions and client services. MediSpend provides commercial compliance solutions for the largest pharmaceutical, medical device and dental companies as well as emerging biotech companies across the world. © Baker Tilly Advisory Group, LP View source version on Contacts Nicole 612 876 4891 BakerTilly Media Relationspress@
Business Wire
3 days ago
- Business Wire
Baker Tilly and MediSpend Expand compliance NOW suite with Launch of stewardship NOW to Transform Life Sciences Compliance
CHICAGO--(BUSINESS WIRE)--Building on its collaboration with MediSpend, leading advisory, tax and assurance firm Baker Tilly announces the expansion of its healthcare compliance platform, compliance NOW, with the launch of stewardshipNOW, a comprehensive compliance solution that streamlines external funding management for life sciences organizations. Powered by MediSpend, and building off of the success of engagementNOW, stewardship NOW automates the administration of grants, charitable contributions, sponsorships and investigator-initiated research funding. The solution helps life sciences companies align healthcare funding initiatives with corporate values while meeting evolving regulatory requirements. With configurable workflows, customizable portals and robust compliance oversight, stewardship NOW simplifies funding processes from submission through payment execution and reconciliation. 'stewardship NOW empowers life sciences companies to manage the complexities with external funding in a compliant, ethical and efficient way,' said Darren Jones, Baker Tilly principal, life sciences consulting. 'Our collaboration with MediSpend combines strategic insight with advanced technology, helping organizations reduce administrative burden, mitigate risk and execute their funding strategies with confidence and integrity.' Life sciences organizations rely on solutions like stewardship NOW to manage programs for continuing medical education, charitable contributions, corporate sponsorships and patient advocacy funding. Baker Tilly supports organizations in developing global philanthropy strategies, implementing robust compliance controls and driving impactful funding initiatives that respect recipient independence and align with corporate values. 'stewardship NOW marks an important next step in our continued collaboration with Baker Tilly, bringing together our built for purpose technology along with their advisory experience to help life sciences organizations more effectively create and run efficient, transparent and compliant funding programs.' said Seth Houston, Chief Commercial Officer at MediSpend. 'We're excited to continue our collaboration with Baker Tilly to support our shared clients as they make impactful contributions to the healthcare industry.' Baker Tilly and MediSpend together deliver technology-enabled solutions that help life sciences organizations navigate complex global regulations, reduce risk and improve operational efficiency. The firm's complianceNOW suite also includes: transparency NOW – A user-friendly platform that streamlines data capture, collection and reporting while helping organizations stay ahead of evolving regulations. engagement NOW – A comprehensive solution for managing engagements and interactions with healthcare professionals. kol NOW – An on-demand, self-service portal that streamlines the process of evaluating the expertise of key opinion leaders (KOLs) used in consulting engagements. fmv NOW – Direct, self-service access to fair market value (FMV) hourly rates across key opinion leader (KOL) tiers, serving as the delivery mechanism for fair market value rate analysis. For more information about Baker Tilly's compliance NOW solutions, visit: # # # About Baker Tilly ( Baker Tilly is a leading advisory, tax and assurance firm, providing clients with a genuine coast-to-coast and global advantage in major regions of the U.S. and in many of the world's leading financial centers – New York, London, San Francisco, Los Angeles, Chicago and Boston. Baker Tilly Advisory Group, LP and Baker Tilly US, LLP (Baker Tilly) provide professional services through an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly US, LLP is a licensed independent CPA firm that provides attest services to its clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and business advisory services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities are not licensed CPA firms. Baker Tilly Advisory Group, LP and Baker Tilly US, LLP, trading as Baker Tilly, are independent members of Baker Tilly International, a worldwide network of independent accounting and business advisory firms in 143 territories, with 43,500 professionals and a combined worldwide revenue of $5.62 billion. Visit or join the conversation on LinkedIn, Facebook and Instagram. MediSpend's best-in-class solutions empower life sciences companies to grow their business compliantly through top-rated solutions and client services. MediSpend provides commercial compliance solutions for the largest pharmaceutical, medical device and dental companies as well as emerging biotech companies across the world. © Baker Tilly Advisory Group, LP
